
Twelve years of multiples investors have paid for Valiant Organics Ltd, framed against the sector median so the premium or discount is obvious at a glance.
Valiant Organics Ltd trades at a P/E of 23.46× and P/B of 1.05×.
Twelve years of audited numbers for Valiant Organics Ltd, switchable between annual and quarterly views, consolidated or standalone.
Valiant Organics Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹789.59 Cr and reported EPS of ₹11.85.
| Period | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 692 | 675 | 755 | 1,153 | 1,052 | 723 | 719 | 739 |
| Other Income | 9 | 21 | 6 | 7 | 8 | 9 | 9 | 7 |
| Total Income | 701 | 696 | 761 | 1,161 | 1,060 | 732 | 727 | 746 |
| Cost of Goods Sold (COGS) | 426 | 393 | 419 | 775 | 688 | 489 | 457 | 437 |
| Gross Profit | 266 | 282 | 336 | 378 | 363 | 234 | 262 | 301 |
| +Operating Expenses | 86 | 103 | 131 | 173 | 199 | 196 | 208 | 213 |
| EBITDA | 180 | 179 | 205 | 205 | 164 | 38 | 54 | 88 |
| +Non-Operating Expenses | 17 | 18 | 26 | 36 | 45 | 48 | 59 | 63 |
| Profit Before Tax (PBT) | 171 | 183 | 185 | 176 | 137 | -7 | 3 | 43 |
| +Tax Expense | 50 | 42 | 54 | 48 | 35 | -0 | 6 | 9 |
| Profit After Tax (PAT) | 121 | 141 | 131 | 128 | 103 | -8 | -3 | 33 |
| Earnings Per Share (EPS) | 113.60 | 57.01 | 42.19 | 41.72 | 32.45 | -3.04 | -1.33 | 11.86 |
| Diluted Shares Outstanding (Nos.) | 1 | 2 | 3 | 3 | 3 | 3 | 3 | 3 |
| +Additional Disclosures | 968 | 909 | 1,018 | 1,775 | 1,631 | 1,224 | 1,180 | 1,145 |
| Sales Growth % | — | -2.51 | 11.83 | 52.79 | -8.80 | -31.26 | -0.59 | 2.78 |
| YoY Sales Growth % | — | -2.51 | 11.83 | 52.79 | -8.80 | -31.26 | -0.59 | 2.78 |
| Material Cost % | 60 | 57 | 55 | 68 | 65 | 67 | 61 | 60 |
| Employee Cost % | 3 | 3 | 4 | 3 | 4 | 7 | 6 | 7 |
| Other Cost % | 10 | 12 | 13 | 12 | 15 | 20 | 23 | 22 |
| OPM % | 26 | 27 | 27 | 18 | 16 | 5 | 7 | 12 |
| Tax % | 29 | 23 | 29 | 27 | 25 | 4 | 191 | 20 |
| Profit Growth % | — | 15.90 | -6.88 | -2.26 | -19.82 | -108.19 | 59.18 | 1,069.46 |
| Gross Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Additional Fields | 166 | 164 | 184 | 175 | 135 | 3 | 18 | 49 |
Disclosed business segments at Valiant Organics with their share of revenue and profit, switchable between consolidated and standalone reporting.
Valiant Organics discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Why someone would buy Valiant Organics Ltd, why someone wouldn't, and the quantitative tripwires that would force the call to flip.
Valiant Organics Ltd's investment case rests on 9 positive markers and 10 flagged concerns drawn from the latest reported filings.
Exceptional quarterly profit growth of 1423.00% signals strong recent performance.
Robust quarterly sales growth of 21.70% indicates increasing market demand.
Low debt-to-equity ratio of 0.34 provides financial stability and flexibility.
Diverse specialty chemical product portfolio serves multiple critical industries globally.
International market presence across Europe, Asia, and the United States.
Negative Return on Equity (-1.19%) indicates current unprofitability and efficiency issues.
Extremely high P/E ratio of 156.96 suggests significant overvaluation or low earnings.
Stock price declined 34.85% over 52 weeks, showing poor long-term momentum.
Promoter holding has been declining, raising concerns about ownership dilution.
Low operating margin (2.49%) and negative net profit margin (-0.51%) are concerning.
Trim if P/E re-rates above 30. The valuation cushion thins from there.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 34.20. Balance sheet risk re-prices growth multiples fast.
Exit if ROE slips below 8%. The operating engine is no longer compounding capital efficiently.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Valiant Organics Ltd is highlighted for quick read-across.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Valiant Organics Ltd — derived from the live tape, not yesterday's close.
Valiant Organics Ltd last traded at ₹282.9 with an intraday range of ₹278.05–₹293.85 — live indicator, pivot and CPR signals below.
Standard pivot — most widely referenced.
| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 323.42 | +40.52 | +14.32% |
| R3 | 307.62 | +24.72 | +8.74% |
| R2 | 300.73 | +17.83 | +6.30% |
| R1 | 291.82 | +8.92 | +3.15% |
| PIVOT | 284.93 | 2.03 | 0.72% |
| CURRENT | 282.90 | — | — |
| S1 | 244.42 | -38.48 | -13.60% |
| S2 | 260.22 | -22.68 | -8.02% |
| S3 | 269.13 | -13.77 | -4.87% |
| S4 | 276.02 | -6.88 | -2.43% |
VALIANTORG is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: 282.1 ~ 293.85
Trading Inside opening range
Daily traded volume and delivery percentage for Valiant Organics Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Valiant Organics Ltd stood at 53.4% of traded volume, against a 20-day average of 46.3%.
Filings Valiant Organics sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Valiant Organics files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 62 documents below.
Valiant Organics Limited has informed the Exchange about Investor Presentation
Valiant Organics Limited has informed the Exchange about Copy of Newspaper Publication
Valiant Organics Limited has informed the Exchange about Copy of Newspaper Publication regarding second 100 days campaign - "Saksham Niveshak"
Valiant Organics Limited has informed the Exchange about Second 100-Day Campaign - ''Saksham Niveshak''
Valiant Organics Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Every dividend, stock split and bonus issue Valiant Organics has declared, sequenced by announce and record date.
Valiant Organics corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
What Valiant Organics Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Valiant Organics Ltd operates in the Basic Materials, listed as NSE: VALIANTORG, BSE: 540145.

Valiant Organics Limited is an Indian chemical manufacturing company specializing in the production and marketing of specialty chemicals. Established in 1984 and headquartered in Mumbai, the company's core business revolves around the synthesis and distribution of a diverse portfolio of chemical intermediates. These intermediates serve as crucial building blocks in various downstream industries, highlighting the company's significant role in the broader chemical supply chain.
Their product range is extensive and includes a wide array of aromatic amines, chlorophenols, and other organic compounds. Specific examples include para chloro phenol, ortho chloro phenol, various fluoroanilines, dichlorophenoxyacetic acid, and numerous isomers of chloro- and nitro-substituted anilines and anisoles. This broad portfolio allows Valiant Organics to cater to a substantial number of clients across diverse sectors.
The primary applications of Valiant Organics' products lie in the manufacturing of agrochemicals, dyes, pigments, pharmaceuticals, cosmetics, specialty chemicals, polymers, and veterinary drugs. This demonstrates the versatility and importance of their chemical intermediates in a wide range of end-use products, contributing to various sectors of the global economy.
Valiant Organics' market reach extends beyond India's borders, with a significant portion of their production exported to Europe, Asia, and the United States. This international presence underscores their competitive position in the global specialty chemicals market and their ability to meet international quality standards and regulatory requirements.
In summary, Valiant Organics Limited operates as a key player in the Indian and global specialty chemicals industry, providing essential intermediates for a broad spectrum of manufacturing processes. Their diverse product portfolio, established international presence, and focus on high-quality production solidify their position within this competitive market.
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
The current share price of Valiant Organics Ltd (VALIANTORG) is ₹282.9. Today, the stock has gained by ₹2.75 (0.98%), trading in a range of ₹278.05 to ₹293.85. The stock opened at ₹293.85 with a trading volume of 44,417 shares.
Valiant Organics Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹789.59 crores, P/E ratio of 23.46, ROE of 4.48%, and ROCE of 2.63%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Valiant Organics Ltd (VALIANTORG) is ₹470.75, while the 52-week low is ₹195. Currently trading at ₹282.9, the stock is 31.9% away from its 52-week low and 39.9% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Valiant Organics Ltd stock at ₹282.9 depends on multiple factors. The stock is currently trading with a P/E ratio of 23.46 and P/B ratio of 1.05. Today's performance shows a gain of 0.98%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Valiant Organics Ltd offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹282.9, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Valiant Organics Ltd's key financial metrics include: P/E Ratio: 23.46, P/B Ratio: 1.05, ROE: 4.48%, ROCE: 2.63%, Dividend Yield: 0.00%, EPS: ₹11.85, Book Value: ₹263.63, and Debt-to-Equity: 33.70. The company's market cap stands at ₹789.59 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Valiant Organics Ltd stock opened at ₹293.85 and is currently trading at ₹282.9, showing a gain of ₹2.75 (0.98%). The intraday high is ₹293.85 and low is ₹278.05. The trading volume stands at 44,417 shares, indicating moderate market participation today.
Valiant Organics Ltd has a Price-to-Earnings (P/E) ratio of 23.46, which means investors are willing to pay ₹23.46 for every ₹1 of earnings. With an EPS of ₹11.85, this P/E ratio indicates moderate valuation in line with market standards. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Valiant Organics Ltd (VALIANTORG) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.
Peers, sector trends, screeners and strategy playbooks contextual to this stock.